What is the starting dose of Lantus (insulin glargine) for a patient previously taking another form of insulin or diabetes medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Dose of Lantus When Transitioning from Another Insulin

For patients with type 2 diabetes previously on insulin, start Lantus at 0.1-0.2 units/kg/day (typically 10 units once daily for most patients), and for those with type 1 diabetes, use 0.4-1.0 units/kg/day total daily insulin with approximately 40-50% given as Lantus. 1, 2

Type 2 Diabetes: Transitioning from Other Insulin

When converting from another basal insulin (NPH, detemir) to Lantus, use a unit-to-unit conversion as the starting point, then titrate based on fasting glucose. 1 However, if the patient was on high-dose home insulin (≥0.6 units/kg/day), reduce the total daily dose by 20% to prevent hypoglycemia. 1

Specific Conversion Scenarios:

  • From NPH or detemir to Lantus: Convert unit-to-unit, but if the patient was on twice-daily NPH, the total daily NPH dose can be given as a single daily Lantus dose 1, 3
  • From detemir to glargine: The total daily dose of glargine should be approximately 38% lower than the total daily dose of detemir (or conversely, detemir requires 38% higher dosing than glargine for equivalent control) 1
  • From premixed insulin (e.g., NovoMix, Mixtard): Calculate the total daily insulin dose from the premixed regimen, then split 50% as Lantus once daily and 50% as prandial insulin divided among three meals 1

Titration Algorithm After Conversion:

  • Increase by 2 units every 3 days if fasting glucose is 140-179 mg/dL 1, 4
  • Increase by 4 units every 3 days if fasting glucose is ≥180 mg/dL 1, 4
  • Target fasting glucose: 80-130 mg/dL 1, 4
  • If hypoglycemia occurs, reduce dose by 10-20% immediately 1

Type 1 Diabetes: Transitioning from Other Insulin

For type 1 diabetes, calculate total daily insulin requirements at 0.4-1.0 units/kg/day (typically 0.5 units/kg/day for metabolically stable patients), with 40-50% given as Lantus and 50-60% as prandial insulin. 1, 2

Conversion from Insulin Pump:

When transitioning from an insulin pump to Lantus injections, use the 24-hour basal rate from the pump as the starting Lantus dose, typically divided into two doses given 12 hours apart (since type 1 patients often require twice-daily Lantus for adequate 24-hour coverage). 2, 3

Conversion from Multiple Daily Injections:

Add up the total current basal insulin dose (NPH or detemir), and convert unit-to-unit to Lantus, maintaining the same total daily prandial insulin dose. 1

Critical Thresholds and When to Add Prandial Coverage

When basal insulin exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day, adding or intensifying prandial insulin becomes more appropriate than continuing to escalate basal insulin alone. 1 Signs of "overbasalization" include:

  • Basal dose >0.5 units/kg/day 1
  • Bedtime-to-morning glucose differential ≥50 mg/dL 1
  • Hypoglycemia episodes 1
  • High glucose variability throughout the day 1

Special Population Dose Adjustments

High-Risk Patients Requiring Lower Doses:

  • Elderly (>65 years): Start with 0.1-0.25 units/kg/day 1
  • Renal impairment (eGFR <60 mL/min/1.73 m²): Start with 0.1-0.25 units/kg/day; for CKD Stage 5, reduce total daily insulin by 50% for type 2 diabetes or 35-40% for type 1 diabetes 1
  • Poor oral intake or acute illness: Use 0.1-0.25 units/kg/day 1
  • Patients with retinopathy: Consider starting dose of 0.12 units/kg/day 5

Patients on High-Dose Home Insulin:

For hospitalized patients previously on ≥0.6 units/kg/day at home, reduce the total daily dose by 20% upon admission to prevent hypoglycemia. 1

Foundation Therapy Considerations

Continue metformin at maximum tolerated dose (up to 2000-2550 mg daily) when initiating or converting to Lantus, as this combination provides superior glycemic control with reduced insulin requirements and less weight gain. 1, 4 Consider discontinuing sulfonylureas when advancing beyond basal-only insulin to prevent hypoglycemia. 1

Common Pitfalls to Avoid

  • Never use sliding scale insulin as monotherapy when converting to Lantus; always establish a scheduled basal-bolus regimen 1
  • Do not continue escalating Lantus beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia with prandial insulin 1
  • Never discontinue metformin when starting or converting to insulin unless contraindicated 1, 4
  • Do not delay insulin dose adjustments; 75% of hospitalized patients who experienced hypoglycemia had no basal insulin dose adjustment before the next administration 1

Monitoring Requirements

  • Daily fasting blood glucose monitoring is essential during titration 1, 4
  • Reassess adequacy of insulin dose at every clinical visit, looking for signs of overbasalization 1
  • Check HbA1c every 3 months during intensive titration 1

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Insulin Glargine Starting Dose Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Insulin Glargine: a review 8 years after its introduction.

Expert opinion on pharmacotherapy, 2009

Guideline

Insulin Glargine Dispensing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.